✓ At present, it is not clear why drug tolerance develops in patients receiving intrathecal baclofen for the chronic treatment of spasticity of spinal origin. To investigate the mechanisms of tolerance to the gamma-aminobutyric acid (GABAB) agonist baclofen, rats were implanted with intrathecal catheters and continuously infused with either the drug or saline for 1, 3, or 7 days. The dose chosen, 1 µg/hr, initially caused profound hindlimb motor weakness, but by Day 7 the rats had adapted to the drug and exhibited only minimal motor impairment. The animals were sacrificed on Day 1, 3, or 7 and quantitative autoradiography was used to determine the binding density and affinity of the GABAB receptors in the substantia gelatinosa of the lumbar spinal cord. After I day of drug infusion there was no change in binding parameters, but after 3 and especially after 7 days there was a significant decrease in the GABAB binding density (74% and 66%, respectively) in baclofen-treated rats as compared to saline-treated control rats. This GABAB receptor down-regulation correlated with tolerance to the motor weakness in the baclofen-treated animals and suggests that similar mechanisms contribute to drug tolerance in patients.
Benovic JL, , Bouvier M, & Caron MG, et al: Regulation of adenylyl cyclase-coupled β-adrenergic receptors. Annu Rev Cell Biol 4:405–428, 1988 Benovic JL, Bouvier M, Caron MG, et al: Regulation of adenylyl cyclase-coupled β-adrenergic receptors. Annu Rev Cell Biol 4:405–428, 1988
Bhargara HN, & Gulati A: Down-regulation of brain and spinal cord μ-opiate receptors in morphine tolerant-dependent rats. Eur J Pharmacol 190:305–311, 1990 Bhargara HN, Gulati A: Down-regulation of brain and spinal cord μ-opiate receptors in morphine tolerant-dependent rats. Eur J Pharmacol 190:305–311, 1990
Bowery NG, , Hill DR, & Hudson AL: Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. Br J Pharmacol 78:191–206, 1983 Bowery NG, Hill DR, Hudson AL: Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. Br J Pharmacol 78:191–206, 1983
Brugger F: GABAB receptors in the spinal cord. Pharmacol Commun 2:127–130, 1992 Brugger F: GABAB receptors in the spinal cord. Pharmacol Commun 2:127–130, 1992
Chu DCM, , Penney JB Jr, & Young AB: Cortical GABAB and GABAA receptors in Alzheimer's disease: a quantitative autoradiographic study. Neurology 37:1454–1459, 1987 Chu DCM, Penney JB Jr, Young AB: Cortical GABAB and GABAA receptors in Alzheimer's disease: a quantitative autoradiographic study. Neurology 37:1454–1459, 1987
Davidoff RA, & Sears ES: The effects of Lioresal on synaptic activity in the isolated spinal cord. Neurology 24:957–963, 1974 Davidoff RA, Sears ES: The effects of Lioresal on synaptic activity in the isolated spinal cord. Neurology 24:957–963, 1974
Drew CA, , Johnston GAR, & Kerr DIB, et al: Inhibition of baclofen binding to rat cerebellar membranes by phaclofen, saclofen, 3-aminopropylphosphonic acid and related GABAB receptor antagonists. Neurosci Lett 113:107–110, 1990 Drew CA, Johnston GAR, Kerr DIB, et al: Inhibition of baclofen binding to rat cerebellar membranes by phaclofen, saclofen, 3-aminopropylphosphonic acid and related GABAB receptor antagonists. Neurosci Lett 113:107–110, 1990
Faden AI, & Simon RP: A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann Neurol 23:623–626, 1988 Faden AI, Simon RP: A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann Neurol 23:623–626, 1988
Gehlert DR, , Yamamura HI, & Wansley JK: γ-Aminobutyric acidB receptors in the rat brain: quantitative autoradiographic localization using [3H] (−)-baclofen. Neurosci Lett 56:183–188, 1985 Gehlert DR, Yamamura HI, Wansley JK: γ-Aminobutyric acidB receptors in the rat brain: quantitative autoradiographic localization using [3H] (−)-baclofen. Neurosci Lett 56:183–188, 1985
Lazorthes Y, , Sallerin-Caute B, & Verdie JC, et al: Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 72:393–402, 1990 Lazorthes Y, Sallerin-Caute B, Verdie JC, et al: Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 72:393–402, 1990
Long JB, , Mobley WC, & Holaday JW: Neurological dysfunction after intrathecal injection of dynorphin A (1–13) in the rat. I. Injection procedures modify pharmacological responses. J Pharmacol Exp Ther 246:1158–1166, 1988 Long JB, Mobley WC, Holaday JW: Neurological dysfunction after intrathecal injection of dynorphin A (1–13) in the rat. I. Injection procedures modify pharmacological responses. J Pharmacol Exp Ther 246:1158–1166, 1988
Loubser PG, , Narayan RK, & Sandin KJ, et al: Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 29:48–64, 1991 Loubser PG, Narayan RK, Sandin KJ, et al: Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 29:48–64, 1991
McCarthy RJ, , Kroin JS, & Lubenow TR, et al: Effect of intrathecal tizanidine on antinociception and blood pressure in the rat. Pain 40:333–338, 1990 McCarthy RJ, Kroin JS, Lubenow TR, et al: Effect of intrathecal tizanidine on antinociception and blood pressure in the rat. Pain 40:333–338, 1990
Mahan LC, , Koachman AM, & Insel PA: Genetic analysis of β-adrenergic receptor internalization and down-regulation. Proc Natl Acad Sci USA 82:129–133, 1985 Mahan LC, Koachman AM, Insel PA: Genetic analysis of β-adrenergic receptor internalization and down-regulation. Proc Natl Acad Sci USA 82:129–133, 1985
Milne B, , Cervenko F, & Jhamandas K, et al: Analgesia and tolerance to intrathecal morphine and norepinephrine infusion via implanted mini-osmotic pumps in the rat. Pain 22:165–172, 1985 Milne B, Cervenko F, Jhamandas K, et al: Analgesia and tolerance to intrathecal morphine and norepinephrine infusion via implanted mini-osmotic pumps in the rat. Pain 22:165–172, 1985
Müller H, , Zierski J, & Dralle D, et al: Intrathecal baclofen in spasticity, in Müller H, , Zierski J, & Penn RD (eds): Local-Spinal Therapy of Spasticity. Berlin: Springer-Verlag, 1988, pp 155–214 Müller H, Zierski J, Dralle D, et al: Intrathecal baclofen in spasticity, in Müller H, Zierski J, Penn RD (eds): Local-Spinal Therapy of Spasticity. Berlin: Springer-Verlag, 1988, pp 155–214
Ochs G, , Struppler A, & Meyerson BA, et al: Intrathecal baclofen for long-term treatment of spasticity: a multi-center study. J Neurol Neurosurg Psychiatry 52:933–939, 1989 Ochs G, Struppler A, Meyerson BA, et al: Intrathecal baclofen for long-term treatment of spasticity: a multi-center study. J Neurol Neurosurg Psychiatry 52:933–939, 1989
Onofrio BM, & Yaksh TL: Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg 72:200–209, 1990 Onofrio BM, Yaksh TL: Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg 72:200–209, 1990
Penn RD: Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 77:236–240, 1992 Penn RD: Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 77:236–240, 1992
Penn RD, & Kroin JS: Continuous intrathecal baclofen for severe spasticity. Lancet 2:125–127, 1985 Penn RD, Kroin JS: Continuous intrathecal baclofen for severe spasticity. Lancet 2:125–127, 1985
Penn RD, & Kroin JS: Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 66:181–185, 1987 Penn RD, Kroin JS: Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 66:181–185, 1987
Penn RD, , Kroin JS, & Magolan JM: Intrathecal baclofen in the treatment of spinal spasticity. Clin Neuropharmacol 13 (Suppl 2):400–401, 1990 Penn RD, Kroin JS, Magolan JM: Intrathecal baclofen in the treatment of spinal spasticity. Clin Neuropharmacol 13 (Suppl 2):400–401, 1990
Penn RD, & Paice JA: Chronic intrathecal morphine for intractable pain. J Neurosurg 67:182–186, 1987 Penn RD, Paice JA: Chronic intrathecal morphine for intractable pain. J Neurosurg 67:182–186, 1987
Penn RD, , Savoy SM, & Corcos D, et al: Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320:1517–1521, 1989 Penn RD, Savoy SM, Corcos D, et al: Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320:1517–1521, 1989
Price GW, , Kelly JS, & Bowery NG: The location of GABABreceptor binding sites in mammalian spinal cord. Synapse 1:530–538, 1987 Price GW, Kelly JS, Bowery NG: The location of GABABreceptor binding sites in mammalian spinal cord. Synapse 1:530–538, 1987
Price GW, , Wilkin GP, & Turnbull MJ, et al: Are baclofensensitive GABAB receptors present on primary afferent terminals of the spinal cord? Nature 307:71–74, 1984 Price GW, Wilkin GP, Turnbull MJ, et al: Are baclofensensitive GABAB receptors present on primary afferent terminals of the spinal cord? Nature 307:71–74, 1984
Rivlin AS, & Tator CH: Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 47:577–581, 1977 Rivlin AS, Tator CH: Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 47:577–581, 1977
Suzdak PD, & Gianutsos G: Effect of chronic imipramine or baclofen on GABA-B binding and cyclic AMP production in cerebral cortex. Eur J Pharmacol 131:129–133, 1986 Suzdak PD, Gianutsos G: Effect of chronic imipramine or baclofen on GABA-B binding and cyclic AMP production in cerebral cortex. Eur J Pharmacol 131:129–133, 1986
Tao PL, , Law PY, & Loh HH: Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J Pharmacol Exp Ther 240:809–816, 1987 Tao PL, Law PY, Loh HH: Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J Pharmacol Exp Ther 240:809–816, 1987
Valiquette M, , Bonin H, & Hnatowich M, et al: Involvement of tyrosine residues located in the carboxyl tail of the human β2-adrenergic receptor in agonist-induced down-regulation of the receptor. Proc Natl Acad Sci USA 87:5089–5093, 1990 Valiquette M, Bonin H, Hnatowich M, et al: Involvement of tyrosine residues located in the carboxyl tail of the human β2-adrenergic receptor in agonist-induced down-regulation of the receptor. Proc Natl Acad Sci USA 87:5089–5093, 1990
Waldvogel HJ, , Faull RLM, & Jansen KLR, et al: GABA, GABA receptors and benzodiazepine receptors in the human spinal cord: an autoradiographic and immunohistochemical study at the light and electron microscopic levels. Neuroscience 39:361–385, 1990 Waldvogel HJ, Faull RLM, Jansen KLR, et al: GABA, GABA receptors and benzodiazepine receptors in the human spinal cord: an autoradiographic and immunohistochemical study at the light and electron microscopic levels. Neuroscience 39:361–385, 1990
Werling LL, , McMahon PN, & Cox BM: Selective changes in μ opioid receptor properties induced by chronic morphine exposure. Proc Natl Acad Sci USA 86:6393–6397, 1989 Werling LL, McMahon PN, Cox BM: Selective changes in μ opioid receptor properties induced by chronic morphine exposure. Proc Natl Acad Sci USA 86:6393–6397, 1989
Wiesenfeld Z, & Gustafsson LL: Continuous intrathecal administration of morphine via an osmotic minipump in the rat. Brain Res 247:195–197, 1982 Wiesenfeld Z, Gustafsson LL: Continuous intrathecal administration of morphine via an osmotic minipump in the rat. Brain Res 247:195–197, 1982
Yaksh TL, , Kohl RL, & Rudy TA: Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space. Eur J Pharmacol 42:275–284, 1977 Yaksh TL, Kohl RL, Rudy TA: Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space. Eur J Pharmacol 42:275–284, 1977
Yaksh TL, & Rudy TA: Chronic catheterization of the spinal subarachnoid space. Physiol Behav 17:1031–1036, 1976 Yaksh TL, Rudy TA: Chronic catheterization of the spinal subarachnoid space. Physiol Behav 17:1031–1036, 1976
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 571 | 145 | 10 |
| Full Text Views | 281 | 16 | 1 |
| PDF Downloads | 154 | 17 | 1 |
| EPUB Downloads | 0 | 0 | 0 |